Sandoz launches azelastine/fluticasone nasal spray in Germany and Switzerland, expanding patient access to high-quality allergy treatment option

Sandoz, the global leader in affordable medicines, announces the launch of its azelastine and fluticasone fixed-dose-combination (FDC) nasal spray in Germany and Switzerland, offering patients in both markets a high-quality allergy treatment option.

The release as fetched from its publisher. sandoz.com ↗